Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (41-50 of 1,356) with videos related to

Pageof 136
Sort By:
Ejhaem|April 18, 2024
Gene expression prognostic of early relapse risk in low-risk B-cell acute lymphoblastic leukaemia in childrenXiaowen Gong, Tianyuan Hu, Qiujin Shen, et al.
Ejhaem|April 18, 2024
Early CAR<sup>-</sup> CD4<sup>+</sup> T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphomaMassimiliano Gambella, Simona Carlomagno, Rosa Mangerini, et al.
Ejhaem|April 18, 2024
Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patientsAlfonso Piciocchi, Marta Cipriani, Monica Messina, et al.
Ejhaem|April 18, 2024
Montreal cognitive assessment in Brazilian adults with sickle cell disease: The burdens of poor sociocultural backgroundPedro Junqueira Fleury Silva, Caroline Martins Silva, Brunno Machado de Campos, et al.
Ejhaem|July 18, 2022
Overview of approved CAR-T therapies, ongoing clinical trials, and its impact on clinical practiceSalyka Sengsayadeth, Bipin N Savani, Olalekan Oluwole, et al.
Ejhaem|July 18, 2022
Chimeric antigen receptor T-cell therapy: Challenges and framework of outpatient administrationKatie S Gatwood, Bhagirathbhai R Dholaria, Mariana Lucena, et al.
Ejhaem|July 18, 2022
Role of bridging therapy during chimeric antigen receptor T cell therapyShakthi T Bhaskar, Bhagirathbhai R Dholaria, Salyka M Sengsayadeth, et al.
Ejhaem|July 18, 2022
Hypereosinophilia with a pinch of salt and pepperAngelantonio Vitucci, Francesco Tarantini, Giuseppe Ingravallo, et al.
Ejhaem|July 18, 2022
Myeloproliferative invasion of arterial walls: Premortem diagnosis by temporal artery biopsyHannah Van Steenberge, Francesca Dedeurwaerdere, Dries Deeren
Ejhaem|July 18, 2022
RUNX inhibitor suppresses graft-versus-host disease through targeting <i>RUNX-NFATC2</i> axisHirohito Kubota, Tatsuya Masuda, Mina Noura, et al.
Pageof 136

Showing results (41-50 of 1,356) with videos related to

Sort By:
Pageof 136
Ejhaem|April 18, 2024
Gene expression prognostic of early relapse risk in low-risk B-cell acute lymphoblastic leukaemia in childrenXiaowen Gong, Tianyuan Hu, Qiujin Shen, et al.
Ejhaem|April 18, 2024
Early CAR<sup>-</sup> CD4<sup>+</sup> T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphomaMassimiliano Gambella, Simona Carlomagno, Rosa Mangerini, et al.
Ejhaem|April 18, 2024
Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patientsAlfonso Piciocchi, Marta Cipriani, Monica Messina, et al.
Ejhaem|April 18, 2024
Montreal cognitive assessment in Brazilian adults with sickle cell disease: The burdens of poor sociocultural backgroundPedro Junqueira Fleury Silva, Caroline Martins Silva, Brunno Machado de Campos, et al.
Ejhaem|July 18, 2022
Overview of approved CAR-T therapies, ongoing clinical trials, and its impact on clinical practiceSalyka Sengsayadeth, Bipin N Savani, Olalekan Oluwole, et al.
Ejhaem|July 18, 2022
Chimeric antigen receptor T-cell therapy: Challenges and framework of outpatient administrationKatie S Gatwood, Bhagirathbhai R Dholaria, Mariana Lucena, et al.
Ejhaem|July 18, 2022
Role of bridging therapy during chimeric antigen receptor T cell therapyShakthi T Bhaskar, Bhagirathbhai R Dholaria, Salyka M Sengsayadeth, et al.
Ejhaem|July 18, 2022
Hypereosinophilia with a pinch of salt and pepperAngelantonio Vitucci, Francesco Tarantini, Giuseppe Ingravallo, et al.
Ejhaem|July 18, 2022
Myeloproliferative invasion of arterial walls: Premortem diagnosis by temporal artery biopsyHannah Van Steenberge, Francesca Dedeurwaerdere, Dries Deeren
Ejhaem|July 18, 2022
RUNX inhibitor suppresses graft-versus-host disease through targeting <i>RUNX-NFATC2</i> axisHirohito Kubota, Tatsuya Masuda, Mina Noura, et al.
Pageof 136